Clinical trial
Study on the Clinical Efficacy of Chinese Medicine Treatment of Sequelae of Apoplexy
NCT03077984 is registered in ClinicalTrials.gov with Tongsheng Su as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Clinical Efficacy of Chinese Medicine Treatment of Sequelae of Apoplexy
- Lead sponsor
- Tongsheng Su
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2020
- Enrollment
- 1,660 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.